Konstantin Mitov
Overview
Explore the profile of Konstantin Mitov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kamusheva M, Manova M, Savova A, Petrova G, Mitov K, Harsanyi A, et al.
Front Pharmacol
. 2018 Aug;
9:795.
PMID: 30079023
The aim of the study was to compare the access of patients with rare diseases (RDs) to biotechnological drugs in several Central and Eastern European countries (CEECs). We focused on...
12.
Boyadzieva V, Stoilov N, Stoilov R, Tachkov K, Kamusheva M, Mitov K, et al.
Front Pharmacol
. 2018 Aug;
9:794.
PMID: 30072903
Biological medicines are considered as a cornerstone in the therapy of rheumatoid arthritis (RA). They change the course of the disease and improve the quality of life of patients. To...
13.
Dimitrova M, Pavlov K, Mitov K, Genov J, Petrova G
Front Med (Lausanne)
. 2017 Aug;
4:125.
PMID: 28824914
Objective: HCV infection is a leading cause of chronic liver disease with long-term complications-extensive fibrosis, cirrhosis, and hepatocellular carcinoma. The objective of this study is to perform cost analysis of...
14.
Kamusheva M, Dimitrova M, van Boven J, Postma M, van der Molen T, Kocks J, et al.
J Med Econ
. 2017 Jan;
20(5):503-509.
PMID: 28058859
Background: While the impact of COPD in Western-Europe is known, data from Eastern-Europe is scarce. This study aimed to evaluate clinical characteristics, treatment patterns, and the socio-economic burden of COPD...
15.
Dimitrova M, Petrova G, Tachkov K, Bozhkova M, Kamusheva M, Mitov K
Biotechnol Biotechnol Equip
. 2015 May;
28(2):366-371.
PMID: 26019522
The purpose of the present analysis is to calculate and compare the costs and results of the implication of the inactivated vaccine against hepatitis A virus (HAV) in the Bulgarian...